Trinity Street Asset Management LLP Decreases Holdings in Cigna Group $CI

Trinity Street Asset Management LLP lessened its stake in shares of Cigna Group (NYSE:CI) by 4.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 75,773 shares of the health services provider’s stock after selling 3,408 shares during the period. Cigna Group comprises about 1.3% of Trinity Street Asset Management LLP’s holdings, making the stock its 20th biggest position. Trinity Street Asset Management LLP’s holdings in Cigna Group were worth $20,855,000 as of its most recent filing with the SEC.

Other large investors have also added to or reduced their stakes in the company. Harbor Capital Advisors Inc. increased its holdings in Cigna Group by 119.5% during the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after buying an additional 49 shares during the last quarter. Beacon Financial Strategies CORP purchased a new stake in Cigna Group during the fourth quarter worth about $28,000. Collier Financial purchased a new stake in Cigna Group during the third quarter worth about $34,000. Lodestone Wealth Management LLC purchased a new stake in Cigna Group during the fourth quarter worth about $32,000. Finally, Founders Capital Management increased its holdings in Cigna Group by 53.0% during the third quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock worth $44,000 after buying an additional 53 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on CI shares. Piper Sandler decreased their price objective on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. UBS Group reiterated a “buy” rating and set a $375.00 target price on shares of Cigna Group in a research report on Monday, February 9th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a research report on Tuesday, February 10th. Guggenheim reiterated a “buy” rating and set a $318.00 target price on shares of Cigna Group in a research report on Monday, February 2nd. Finally, Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $333.11.

Insider Transactions at Cigna Group

In related news, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.60% of the company’s stock.

Cigna Group Stock Performance

Shares of NYSE CI opened at $277.52 on Thursday. The stock has a market cap of $73.13 billion, a price-to-earnings ratio of 12.51, a P/E/G ratio of 0.94 and a beta of 0.26. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The stock’s 50-day moving average is $276.26 and its 200 day moving average is $278.75.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The company had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.Cigna Group’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the firm posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, sell-side analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Thursday, March 5th were issued a dividend of $1.56 per share. The ex-dividend date of this dividend was Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is 28.13%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.